Femtobiomed Inc. (XKON:327610)
South Korea
· Delayed Price · Currency is KRW
4,350.00
-70.00 (-1.58%)
At close: Aug 12, 2025, 3:30 PM KST
Femtobiomed Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2018 | FY 2017 |
| Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
| Net Income | -1,210 | -1,070 |
| Depreciation & Amortization | 124.75 | 141.76 |
| Loss (Gain) From Sale of Assets | - | -1.63 |
| Provision & Write-off of Bad Debts | 1.82 | - |
| Other Operating Activities | 14.02 | 18.74 |
| Change in Accounts Receivable | 47.56 | -14.04 |
| Change in Inventory | -83.05 | 18.89 |
| Change in Accounts Payable | - | -0.92 |
| Change in Other Net Operating Assets | 6.38 | -16.74 |
| Operating Cash Flow | -1,099 | -923.94 |
| Capital Expenditures | -134.72 | -72.21 |
| Sale of Property, Plant & Equipment | - | 31.74 |
| Sale (Purchase) of Intangibles | -91.01 | -10.23 |
| Other Investing Activities | -4.91 | -98.35 |
| Investing Cash Flow | -230.64 | -140.55 |
| Long-Term Debt Repaid | -61.05 | -66.6 |
| Net Debt Issued (Repaid) | -61.05 | -66.6 |
| Financing Cash Flow | -61.05 | -66.6 |
| Net Cash Flow | -1,390 | -1,131 |
| Free Cash Flow | -1,233 | -996.14 |
| Free Cash Flow Margin | -316.28% | -251.83% |
| Free Cash Flow Per Share | -892.82 | -721.51 |
| Levered Free Cash Flow | -890.34 | - |
| Unlevered Free Cash Flow | -889.89 | - |
| Change in Working Capital | -29.1 | -12.82 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.